Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Regeneron's Eylea could lose 30% of its patients to Roche's Vabysmo over the next year: analyst survey
Fierce Pharma
Mon, 06/13/22 - 09:46 pm
Regeneron
Eylea
Vabysmo
Roche
wet-AMD
Roche keeps the faith in new cancer immunotherapy despite trial setbacks
BioPharma Dive
Tue, 06/7/22 - 10:30 am
Roche
tiragolumab
lung cancer
clinical trials
ASCO 2022
ASCO: BioNTech's Roche-partnered cancer vaccine combo hints at survival benefit in prostate cancer
Fierce Biotech
Sun, 06/5/22 - 11:45 pm
ASCO 2022
BioNTech
Roche
vaccines
cancer vaccines
pancreatic cancer
Biogen, Samsung Bioepis launch ranibizumab-nuna in US
Ophthalmology Today
Fri, 06/3/22 - 09:11 am
Biogen
Samsung Bioepis
ranibizumab
ranibizumab-nuna
biosimilars
Roche
Lucentis
retinal disease
Roche pays Repare $125M to join Big Pharma peers in cancer race
Fierce Biotech
Thu, 06/2/22 - 10:36 am
Roche
cancer
ovarian cancer
Repare Therapeutics
Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts
Fierce Pharma
Wed, 06/1/22 - 10:15 am
AbbVie
Roche
Pfizer
Humira
Microcap's effort to take on Eylea with Avastin biosimilar faces significant FDA roadblock
Endpoints
Tue, 05/31/22 - 10:51 am
Outlook Therapeutics
Avastin
biosimilars
wet age-related macular degeneration
Roche
bevacizumab
Roche puts pressure on SMA rivals with new FDA approval
Pharmaforum
Tue, 05/31/22 - 10:33 am
Roche
PTC Therapeutics
SMA
Evrysdi
FDA
Abbvie to become the biggest of pharmas in 2028
EP Vantage
Mon, 05/30/22 - 10:13 am
AbbVie
Humira
Pfizer
Novartis
Bristol Myers Squibb
Roche
Roche trumpets new glofitamab data in lymphoma at ASCO
Pharmaforum
Fri, 05/27/22 - 10:24 am
Roche
ASCO 2022
glofitamab
lymphoma
bispecific antibodies
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
ASCO 2022
AstraZeneca
Enhertu
Gilead Sciences
Trodelvy
Roche
tiragolumab
cancer
Roche unveils three new monkeypox tests as cases rise
Endpoints
Wed, 05/25/22 - 11:38 pm
Roche
diagnostics
monkeypox
Diagnostics beat implants in the race to market
EP Vantage
Tue, 05/24/22 - 10:22 am
diagnostics
devices
Medtech
Roche
Qiagen
Asahi Kasei
Abbott Labs
Roche and bluebird bio settle year-long trademark case, but keep quiet on the details
Endpoints
Thu, 05/19/22 - 08:59 pm
Bluebird Bio
Roche
Spark Therapeutics
trademark
legal
Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
R&D
licensing
M&A
COVID-19
Big Pharma
Bristol Myers Squibb
JNJ
AbbVie
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Roche
GSK
Eli Lilly
EHA 2022 preview – some good news at last
EP Vantage
Mon, 05/16/22 - 10:14 am
EHA
Caribou Biosciences
CB-010
Gracell
Autolus
Roche
Curocell
ADC Therapeutics
Mustang Bio
Checkmate details bleak future if $250M Regeneron merger does not close
Fierce Biotech
Sun, 05/15/22 - 11:17 pm
Checkmate Pharmaceuticals
Roche
M&A
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Novartis
Sandoz
generics
Roche
Esbriet
idiopathic pulmonary fibrosis
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Roche believes cancer drug setback not a fatal blow to growth prospects
Reuters
Thu, 05/12/22 - 10:57 pm
Roche
drug development
tiragolumab
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »